Operose Advisors’s Vericel Corp VCEL Stock Holding History

Operose Advisors’s Portfolio VCEL Stock Details VCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-143	Closed	-$4.79K	–	729
2023 Q3	$4.79K	Buy	+143	New	+$4.96K	﹤0.01%	665

Other funds holding VCEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Operose Advisors's VCEL Position: Q4 2023 in Review

Operose Advisors sold out of Vericel Corp (VCEL) in Q4 2023, closing a stake of 143 shares — an estimated $4.79K sold.

Operose Advisors first reported a position in VCEL in Q3 2023 and held it in 1 quarter. The position peaked at $4.79K in Q3 2023. 227 funds tracked by Wall St. Rank hold VCEL as of Q4 2023.

Operose Advisors reported no remaining Vericel Corp position as of Q4 2023 after selling out during the quarter.
Operose Advisors sold 143 Vericel Corp shares in Q4 2023, an estimated $4.79K.
Operose Advisors first reported a position in Vericel Corp in Q3 2023 and held it in 1 quarter.
Operose Advisors's Vericel Corp position peaked at $4.79K in Q3 2023.
227 funds tracked by Wall St. Rank held Vericel Corp as of Q4 2023.

Based on Operose Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.